Spain Flow Cytometry Market Size & Outlook, 2023-2030
Spain flow cytometry market, 2018-2030 (US$M)
Related Markets
Spain flow cytometry market highlights
- The Spain flow cytometry market generated a revenue of USD 86.0 million in 2023 and is expected to reach USD 125.6 million by 2030.
- The Spain market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 86.0 million |
| Market revenue in 2030 | USD 125.6 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Spain accounted for 2.0% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 403.0 million by 2030.
Instruments was the largest segment with a revenue share of 34.42% in 2023. Horizon Databook has segmented the Spain flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing R&D activities by several Spanish research organizations and pharmaceutical companies for developing novel vaccines & therapeutics for COVID-19 are anticipated to drive the demand for flow cytometry solutions. For instance, in September 2020, Spain initiated clinical trials of Johnson & Johnson COVID-19 vaccine.
In addition, Spain exhibits immense growth potential in flow cytometry solutions due to an increasing interest of investors in innovative biological therapies. For instance, in June 2020, Spain-based Ona Therapeutics closed a USD 33.1 million Series A funding for the development of novel anti-metastasis cancer drugs.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain flow cytometry market size, by product, 2018-2030 (US$M)
Spain Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
